http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Article/list/9398 Treatment and research news and developments about erectile dysfunction, premature ejaculation, Peyronie's disease, and other forms of sexual dysfunction. 2009-11-21T08:33:25Z http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Rehab-is-key-to-restoring-post-RP-erectile-dysfunc/ArticleStandard/Article/detail/384316?contextCategoryId=9398&ref=25 The return and quality of sexual function is a major concern for men undergoing radical prostatectomy. New research on the etiology of post-prostatectomy erectile dysfunction is shaping new rehabilitation strategies for prostatectomy patients, according to John P. Mulhall, MD, who discusses current and future rehabilitation strategies and his own approach to post-prostatectomy ED in this exclusive interview. 2006-11-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452006/384316/346100_thumbnail.jpg http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452006/384316null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Post-radical-prostatectomy-PDE-5-therapy-speeds-er/ArticleStandard/Article/detail/637933?contextCategoryId=9398&ref=25 Postoperative pharmacologic therapy enhances the chances of erectile function recovery in virtually all categories of men who undergo bilateral nerve-sparing prostatectomy. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442009/637933null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Low-testosterone-may-play-role-in-development-of-P/ArticleStandard/Article/detail/637927?contextCategoryId=9398&ref=25 Men with low levels of free testosterone had more severe penile curvature, which correlated significantly with free testosterone, according to results of a retrospective chart review. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442009/637927null XML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Low-testosterone-may-play-role-in-development-of-P/ArticleStandard/Article/detail/638691?contextCategoryId=9398&ref=25 Educate your patients about erectile dysfunction with a free, customizable handout. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452009/638691null REMOTE http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Erectile-dysfunction-linked-with-43-higher-risk-of/ArticleStandard/Article/detail/637930?contextCategoryId=9398&ref=25 Erectile dysfunction increased the risk of cardiovascular death by 43% compared with men who had normal erectile function. 2009-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442009/637930null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Implant-protocol-helps-reduce-penile-shortening/ArticleStandard/Article/detail/633606?contextCategoryId=9398&ref=25 A new noninvasive vacuum protocol for erectile dysfunction patients using an inflatible penile prosthesis can prevent penile shortening. 2009-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/422009/633606null XML http://urologytimes.modernmedicine.com/urologytimes/News/Research-links-cardiometabolic-disorders-urologic-/ArticleStandard/Article/detail/624800?contextCategoryId=9398&ref=25 Dr. Williams and Dr. Nangia discuss the effects of cardiometabolic disorders in aging men. 2009-09-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/372009/624800null REMOTE http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Research-links-cardiometabolic-disorders-urologic-/ArticleStandard/Article/detail/624471?contextCategoryId=9398&ref=25 As research reveals more associations between cardiometabolic disorders and urologic disease, experts are emphasizing the importance of the urologist in detecting cardiometabolic risk factors in patients. 2009-09-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/372009/624471null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Metabolic-disorders-Urologists-unique-role/ArticleStandard/Article/detail/624462?contextCategoryId=9398&ref=25 Urologists are in a unique position to detect cardiometabolic risk factors at an early stage and intervene. 2009-09-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/372009/624462null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Base-International-Index-of-Erectile-Function-scor/ArticleStandard/Article/detail/614286?contextCategoryId=9398&ref=25 A study by psychologists and urologists has found that factors affecting erectile function after prostatectomy have much the same impact after other prostate cancer treatments. 2009-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/312009/614286null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Post-radical-prostatectomy-expectations-about-sexu/ArticleStandard/Article/detail/614300?contextCategoryId=9398&ref=25 A significant number of patients undergoing open or robotic radical prostatectomy have unrealistic expectations about postoperative sexual function. 2009-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/312009/614300null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Study-Cure-rate-of-80-seen-with-male-sling/ArticleStandard/Article/detail/614288?contextCategoryId=9398&ref=25 A non-bone-anchored male sling appears to resolve mild to moderate post-prostatectomy incontinence in up to 80% of patients and may also lead to significant improvement in erectile and sexual function. 2009-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/312009/614288null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Novel-technique-easily-resolves-ischemic-priapism/ArticleStandard/Article/detail/614302?contextCategoryId=9398&ref=25 Researchers at the University of California, San Francisco have developed a new surgical approach they call a "T-shunt" that appears to resolve ischemic priapism efficiently and effectively with minimal morbidity. 2009-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/312009/614302null XML http://urologytimes.modernmedicine.com/urologytimes/Modern+Medicine+Now/Support-growing-slowly-for-testosterone-replacemen/ArticleStandard/Article/detail/593045?contextCategoryId=9398&ref=25 John Mulcahy, MD, PhD, a private practice urologist in Phoenix, expects that testosterone replacement will top the list of sexual dysfunction issues at the upcoming AUA annual meeting in Chicago. 2009-04-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/152009/593045null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Studies-shed-light-on-erectile-function-in-prostat/ArticleStandard/Article/detail/577865?contextCategoryId=9398&ref=25 Erectile dysfunction is a fact of life for many men who receive treatment for prostate cancer, but methods of measuring post-treatment ED and erectile function recovery suffer from a lack of standardization, according to studies presented at the Sexual Medicine Society of North America 2008 Fall Scientific Meeting. 2009-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/052009/577865null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-hypogonadism-tests-aim-to-fill-Androgen-Defici/ArticleStandard/Article/detail/577867?contextCategoryId=9398&ref=25 Researchers are developing promising new tools to improve the diagnosis of hypogonadism. 2009-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/052009/577867null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Post-radical-prostatectomy-patients-report-satisfa/ArticleStandard/Article/detail/577866?contextCategoryId=9398&ref=25 Men who turn to intracavernosal injection (ICI) therapy following prostate surgery can generate a satisfactory rigid erection with as few as five practice (trial) injections, according to studies presented at the 2008 Fall Scientific Meeting of the Sexual Medicine Society of North America. 2009-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/052009/577866null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Phosphodiesterase-5-inhibitor-use-highest-after-la/ArticleStandard/Article/detail/563874?contextCategoryId=9398&ref=25 Radical prostatectomy patients are most likely to use medication for erectile dysfunction after surgery; those who underwent laparoscopic/robotic prostatectomy were most likely to use ED drugs. 2008-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452008/563874null XML http://www.modernmedicine.com/modernmedicine/Surgery/Graftless-penile-correction-Excellent-outcomes/ArticleStandard/Article/detail/553496?contextCategoryId=9398&ref=25 Correcting congenital penile curvature with excision and plicating closure of the tunica albuginea without grafting leads to excellent outcomes. 2008-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/392008/553496null XML http://www.modernmedicine.com/modernmedicine/Erectile+Dysfunction/Testosterone-replacement-therapy-gel-is-effective-/ArticleStandard/Article/detail/553497?contextCategoryId=9398&ref=25 Data show that testosterone replacement therapy in hypogonadal men can be effective in significantly improving insulin sensitivity and sexual function, with durable results. 2008-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/392008/553497null XML http://www.modernmedicine.com/modernmedicine/Surgery/Survey-reveals-gaps-in-basic-knowledge-of-Peyronie/ArticleStandard/Article/detail/553495?contextCategoryId=9398&ref=25 While many US urologists claim to be experts in sexual medicine, few know how to treat Peyronie'd disease. 2008-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/392008/553495null XML http://www.modernmedicine.com/modernmedicine/Obstetrics%2FGynecology+%26+Women%27s+Health/Lower-urinary-tract-symptoms-impact-on-womens-sexu/ArticleStandard/Article/detail/553498?contextCategoryId=9398&ref=25 Lower urinary tract symptoms can put a damper on many women's sexual enjoyment and activity. 2008-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/392008/553498null XML http://www.modernmedicine.com/modernmedicine/Erectile+Dysfunction/Post-prostate-cancer-treatment-erectile-dysfunctio/ArticleStandard/Article/detail/543648?contextCategoryId=9398&ref=25 Studies in the field of sexual dusfunction suggest urologists don't know as much as they think they do about Peyronie's disease and that incidence of erectile dysfunction has other implications. 2008-08-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/342008/543648null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/Studies-show-positive-results-of-TRT-gel-formulati/ArticleStandard/Article/detail/526001?contextCategoryId=9398&ref=25 Two testosterone gel formulations are efficacious in obese men and those with diabetes, according to separate studies reported at the Endocrine Society annual meeting in San Francisco. 2008-06-26T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/262008/526001null HTML http://urologytimes.modernmedicine.com/urologytimes/Enews/Panel-develops-definition-of-premature-ejaculation/ArticleStandard/Article/detail/521110?contextCategoryId=9398&ref=25 The International Society for Sexual Medicine has developed an evidence-based definition of premature ejaculation that its authors say will aid future diagnosis, treatment, and research. 2008-06-05T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232008/521110null HTML http://www.modernmedicine.com/modernmedicine/News/Not-men-only-Premature-ejaculation-adversely-affec/ArticleStandard/Article/detail/520518?contextCategoryId=9398&ref=25 Results of a recent study have shown that female partners of men suffering from premature ejaculation (PE) confirm the lack of ejaculatory control of their partners. Significantly lower sexual satisfaction as well as higher ejaculation-related distress and interpersonal difficulties in the relationship were also seen in both male and female participants, compared to relationships in which PE was not an issue. 2008-06-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232008/520518null XML http://www.modernmedicine.com/modernmedicine/News/Investigational-premature-ejaculation-therapy-impr/ArticleStandard/Article/detail/520519?contextCategoryId=9398&ref=25 Dapoxetine, a drug currently under investigation for the treatment of premature ejaculation, provides significant improvement in the sexual function of men and their sexual partners, according to the results of a recent multinational study. 2008-06-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232008/520519null XML http://www.modernmedicine.com/modernmedicine/News/Injection-therapy-salvages-25-of-PDE-5-failures/ArticleStandard/Article/detail/520520?contextCategoryId=9398&ref=25 About one-quarter of men who fail to respond to phosphodiesterase type-5 (PDE-5) inhibitors for treatment of erectile dysfunction will respond to the drug on rechallenge if they are first exposed to a short-term course of intracavernosal injection (ICI) therapy. 2008-06-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232008/520520null XML http://www.modernmedicine.com/modernmedicine/Perspective/Premature-ejaculation-A-common-problem-with-a-prom/ArticleStandard/Article/detail/520515?contextCategoryId=9398&ref=25 Premature ejaculation (PE) is a common problem estimated to affect between 20% and 40% of men. The distress of this condition is actually felt by both partners. 2008-06-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232008/520515null XML http://urologytimes.modernmedicine.com/urologytimes/2008+AUA+News/Investigational-PE-Rx-improves-QoL-in-men-partners/ArticleStandard/Article/detail/518156?contextCategoryId=9398&ref=25 Dapoxetine, a drug currently under investigation for the treatment of premature ejaculation, provides significant improvement in the sexual function of men and their sexual partners, according to the results of a recent multinational study presented here. 2008-05-20T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/212008/518156null HTML http://urologytimes.modernmedicine.com/urologytimes/Online+Only/Survey-results-make-case-for-establishing-Peyronie/ArticleStandard/Article/detail/517895?contextCategoryId=9398&ref=25 Results of a survey of Peyronie's disease knowledge and practice patterns among urologists in the United States raise concerns and speak to the need for developing Peyronie's disease guidelines, John P. Mulhall, MD, said at the AUA annual meeting. 2008-05-19T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/212008/517895null HTML http://urologytimes.modernmedicine.com/urologytimes/Online+Only/Use-of-ED-pharmacotherapy-highest-immediately-afte/ArticleStandard/Article/detail/517600?contextCategoryId=9398&ref=25 Radical prostatectomy patients are most likely to employ pharmacotherapy for erectile dysfunction in the immediate postoperative period, with those who undergo laparoscopic/robotic prostatectomy having the greatest rate of usage, investigators from Brigham and Women's Hospital and Harvard Medical School in Boston reported here. 2008-05-18T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/212008/517600null HTML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Research-helps-unmask-fallacies-about-Peyronies/ArticleStandard/Article/detail/517410?contextCategoryId=9398&ref=25 Misconceptions about the origin of Peyronie's disease can lead to therapeutic strategies that have little or no chance of succeeding, according to Dr. Mulcahy. 2008-05-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/202008/517410null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/ED-heart-disease-awareness-campaign-aims-to-save-m/ArticleStandard/Article/detail/515002?contextCategoryId=9398&ref=25 Taking the relationship between erectile dysfunction and cardiovascular disease to a new level, American Medical Systems has launched a campaign to “Save 100 Additional Lives” through heightened patient awareness about the issue of ED as a potential detector of heart and vascular disease. The program was initiated recently through physician outreach by leading cardiologists and urologists in the Chicago area. 2008-05-08T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/192008/515002null HTML http://www.modernmedicine.com/modernmedicine/News/Hypogonadism-may-be-culprit-in-young-men-with-ED/ArticleStandard/Article/detail/515196?contextCategoryId=9398&ref=25 Although erectile dysfunction in young men is most frequently attributed to psychogenic causes, hypogonadism may be the underlying etiology in an appreciable proportion of these patients. 2008-05-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/192008/515196null XML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Investigational-agent-appears-effective-in-prematu/ArticleStandard/Article/detail/508489?contextCategoryId=9398&ref=25 Oral dapoxetine demonstrates benefits in both men with premature ejaculation and their partners, report the authors of a multinational phase III clinical trial. 2008-04-10T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/152008/508489null HTML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Pre-treatment-antibiotic-dip-may-deter-post-penile/ArticleStandard/Article/detail/506908?contextCategoryId=9398&ref=25 Results of a study comparing the in vitro antibacterial activity of antibiotic-dipped and non-antibiotic-dipped components of inflatable penile implants show differences favoring Titan implants dipped into antibiotic solutions of rifampin-gentamicin or bacitracin-gentamicin compared with the antibiotic (rifampin-minocycline)-coated technology of Inhibizone. 2008-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142008/506908null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Extender-device-yields-good-results-in-Peyronies-d/ArticleStandard/Article/detail/506911?contextCategoryId=9398&ref=25 Daily use of a penile extender device shows promise as a safe, effective, and noninvasive treatment for Peyronie's disease. 2008-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142008/506911null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Data-support-utility-of-sexual-function-questionna/ArticleStandard/Article/detail/506910?contextCategoryId=9398&ref=25 Outcomes with a new sexual function questionnaire correlate well with validated measures of psychosocial function, patient satisfaction, erection hardness, erectile function, and sexual function. 2008-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142008/506910null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Antiseptic-may-reduce-time-prior-to-penile-implant/ArticleStandard/Article/detail/506909?contextCategoryId=9398&ref=25 Chicago—A preoperative skin preparation product may be an effective, time-saving alternative for reducing skin bacterial counts preoperatively in men undergoing penile prosthesis surgery, say the authors of a pilot study from the University of South Florida, Tampa. 2008-04-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142008/506909null XML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/FDA-approves-new-ED-drug-dose-for-once-daily-use/ArticleStandard/Article/detail/486693?contextCategoryId=9398&ref=25 The FDA has approved a new lower-dose regimen of tadalafil (Cialis), an oral erectile dysfunction medication for once-daily use. The 2.5-mg formulation is intended for use by men with ED who anticipate sexual activity at least twice weekly. For other men, the previously approved 5-mg dosing regimen is indicated. 2008-01-31T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/042008/486693null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Testosterone-supplementation-shows-limited-benefit/ArticleStandard/Article/detail/482678?contextCategoryId=9398&ref=25 Older men with low testosterone levels who received testosterone supplementation increased lean body mass and decreased body fat, but were no stronger and had no improvement in mobility or cognition compared with men who did not use the supplement, according to a study published in JAMA (2008; 299:39-52). 2008-01-10T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/022008/482678null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Various-treatments-for-premature-ejaculation-show-/ArticleStandard/Article/detail/482229?contextCategoryId=9398&ref=25 Premature ejaculation, an often-neglected aspect of men's sexual health, is now receiving extensive attention and an influx of research. 2008-01-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/022008/482229null XML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Monitor-PSA-closely-in-testosterone-therapy-patien/ArticleStandard/Article/detail/482228?contextCategoryId=9398&ref=25 Although there is no confirmed direct link between testosterone replacement therapy and prostate cancer, a recent study suggests that physicians treating middle-aged hypogonadal men with extrinsic testosterone should be more vigilant in monitoring these patients' PSA levels than they would be in monitoring average men of the same age. 2008-01-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/022008/482228null XML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/PDE-5-inhibitor-improves-ED-in-men-with-dyslipidem/ArticleStandard/Article/detail/480229?contextCategoryId=9398&ref=25 Vardenafil (Levitra) significantly improves the ability of men with erectile dysfunction and dyslipidemia to achieve and maintain an erection for successful sexual intercourse, according to a study presented at the Sexual Medicine Society of North America winter scientific meeting in Chicago. 2007-12-20T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/512007/480229null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/FDA-accepts-new-drug-application-for-ED-topical-cr/ArticleStandard/Article/detail/477273?contextCategoryId=9398&ref=25 FDA has accepted a new drug application for a topically applied alprostadil cream for the treatment of erectile dysfunction, according to NexMed, Inc., the drug’s developer. 2007-12-06T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/492007/477273null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/FDA-accepts-NDA-for-long-acting-testosterone-drug/ArticleStandard/Article/detail/472510?contextCategoryId=9398&ref=25 The FDA has accepted Indevus Pharmaceuticals’ new drug application for its long-acting depot preparation of testosterone undecanoate (Nebido) for the treatment of male hypogonadism. The NDA is predicated on data from six clinical studies in which more than 400 patients received at least one dose of the drug, more than 300 of whom were treated for more than 1 year. 2007-11-15T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/462007/472510null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/FDA-announces-revisions-to-three-ED-drug-labels/ArticleStandard/Article/detail/468957?contextCategoryId=9398&ref=25 The FDA has approved labeling changes for erectile dysfunction drugs in the class that includes tadalafil (Cialis), vardenafil (Levitra), and sildenafil citrate (Viagra), to display more prominently the potential risk of sudden hearing loss and to guide consumers on what to do if they experience sudden problems with their hearing. 2007-11-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442007/468957null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Sexual-activity-can-be-safe-in-men-with-chronic-he/ArticleStandard/Article/detail/465644?contextCategoryId=9398&ref=25 With proper screening and treatment, many patients with chronic heart failure can safely engage in sexual activity, according to a review published in the Mayo Clinic Proceedings (2007; 82:1203-10). 2007-10-18T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/422007/465644null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Company-files-new-drug-application-for-topical-ED-/ArticleStandard/Article/detail/461926?contextCategoryId=9398&ref=25 NexMed, Inc., a developer of transdermal products based on its proprietary NexACT drug delivery technology, has filed a new drug application for its topically applied alprostadil cream for the treatment of erectile dysfunction. 2007-10-04T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/402007/461926null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Drug-improves-erectile-function-in-men-with-spinal/ArticleStandard/Article/detail/458046?contextCategoryId=9398&ref=25 Tadalafil (Cialis) appears to improve erectile function in men with spinal cord injuries, according to a French study published in the online edition of Archives of Neurology. 2007-09-20T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/382007/458046null HTML http://urologytimes.modernmedicine.com/urologytimes/Prostate+Cancer/Younger-brachytherapy-patients-likely-to-maintain-/ArticleStandard/Article/detail/453751?contextCategoryId=9398&ref=25 Prostate cancer patients younger than 60 years who had healthy erectile function (EF) prior to low doses of brachytherapy have a strong likelihood of sustaining long-term EF, according to a study by radiation oncologists and urologists at Mount Sinai School of Medicine in New York. 2007-09-06T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/352007/453751null HTML http://urologytimes.modernmedicine.com/urologytimes/Inflammation+and+Infection/ED-premature-ejaculation-common-in-prostatitis-pat/ArticleStandard/Article/detail/453761?contextCategoryId=9398&ref=25 Sexual dysfunction is common in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), regardless of the type of CP/CPPS they have, according to two recent studies. 2007-09-06T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/352007/453761null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Sildenafils-effects-may-extend-beyond-sexual-organ/ArticleStandard/Article/detail/453784?contextCategoryId=9398&ref=25 Sildenafil citrate (Viagra) may elevate the release of reproductive hormone, according to the authors of an animal study from the University of Wisconsin, Madison. The finding is potentially the first sign of a chemical means by which erectile dysfunction drugs may physically affect the body beyond heightening blood flow to sexual organs. 2007-09-06T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/352007/453784null HTML http://urologytimes.modernmedicine.com/urologytimes/Inflammation+and+Infection/Sexual-dysfunctions-common-in-CPCPPS-patients/ArticleStandard/Article/detail/454972?contextCategoryId=9398&ref=25 Sexual dysfunction is common in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), regardless of the type of CP/CPPS they have. 2007-09-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/362007/454972null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Engineered-cells-shown-to-restore-penile-function/ArticleStandard/Article/detail/449566?contextCategoryId=9398&ref=25 In the area of sexual dysfunction, tomorrow arrived a little earlier than many attendees of the AUA annual meeting may have anticipated. 2007-08-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/332007/449566null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/Gene-therapy-may-yield-marked-improvement-in-ED/ArticleStandard/Article/detail/436576?contextCategoryId=9398&ref=25 Injection of a gene therapy vector in rats with erectile dysfunction enabled the return of normal function within 4 weeks, according to a study from the University of Pittsburgh School of Medicine. The research may be the first step in developing a new mode of long-term ED treatment, researchers say. 2007-06-21T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/252007/436576null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Initiative-encourages-men-to-discuss-ED-symptoms/ArticleStandard/Article/detail/431795?contextCategoryId=9398&ref=25 During the month of June, which is Men's Health Month, the Erectile Dysfunction Institute is encouraging all men who experience erectile dysfunction to discuss their symptoms with visits to their physicians. 2007-06-07T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232007/431795null HTML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Survey-Sexual-dissatisfaction-is-a-global-issue/ArticleStandard/Article/detail/431395?contextCategoryId=9398&ref=25 Sex is important to men and women worldwide, according to findings from a large global survey, yet a significant proportion of men and women are not completely satisfied with their sex lives. 2007-06-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232007/431395null XML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Penile-hemodynamics-predict-cardiovascular-disease/ArticleStandard/Article/detail/431396?contextCategoryId=9398&ref=25 Research has shown that penile hemodynamic findings are related to vascular risk factors. 2007-06-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/232007/431396null XML http://urologytimes.modernmedicine.com/urologytimes/Erectile+Dysfunction/Novel-premature-ejaculation-Peyronies-treatments-t/ArticleStandard/Article/detail/427773?contextCategoryId=9398&ref=25 Sexual dysfunction comprises more than erectile dysfunction, and other conditions that fall into the category often receive a disproportionate amount of public attention. 2007-05-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/202007/427773null XML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Dietary-supplement-containing-ED-drug-is-recalled-/ArticleStandard/Article/detail/423944?contextCategoryId=9398&ref=25 Cosmos Trading, Inc., is conducting a voluntary nationwide recall of its dietary supplement product sold under the name Rhino Max (Rhino V Max) after lab analysis found that the product contains aminotadalafil, an analogue of tadalafil, making Rhino Max (Rhino V Max) an unapproved drug. 2007-05-03T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/182007/423944null HTML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Optimizing-testosterone-replacement-therapy-in-hyp/ArticleStandard/Article/detail/422615?contextCategoryId=9398&ref=25 A panel of experts in men's health and endocrinology recently discussed the impact of hypogonadism on men's health, the benefits and risks of testosterone replacement therapy, and the awareness in the medical community of these issues. This article was developed from the proceedings of that meeting. 2007-05-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/conturo/172007/422615null XML http://urologytimes.modernmedicine.com/urologytimes/2007+Urology+Congress/PDE-5-inhibitors-show-efficacy-in-new-indications-/ArticleStandard/Article/detail/417356?contextCategoryId=9398&ref=25 The therapeutic revolution that began in 1997 when the first phosphodiesterase type-5 inhibitor was approved for erectile dysfunction is poised to expand. ED is just the first, most obvious use for PDE-5 inhibitors, said Culley Carson, MD, of the University of North Carolina, Chapel Hill. 2007-04-07T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142007/417356null HTML http://urologytimes.modernmedicine.com/urologytimes/2007+Urology+Congress/Nonoral-treatment-options-maintain-a-vital-role-in/ArticleStandard/Article/detail/417355?contextCategoryId=9398&ref=25 Phosphodiesterase type-5 inhibitors are the first step in the treatment of erectile dysfunction. But about 30% of men fail to respond to PDE-5 inhibitors, noted Andrew McCullough, MD. Another 20% suffer significant side effects. 2007-04-07T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/142007/417355null HTML http://urologytimes.modernmedicine.com/urologytimes/Prostate+Cancer/False-positive-PSA-results-lead-to-excess-worry-se/ArticleStandard/Article/detail/411602?contextCategoryId=9398&ref=25 Men with prostate cancer screenings that result in false-positive results are approximately three times as likely to indicate some degree of concern about developing prostate cancer, and are nearly twice as likely to experience impaired sexual function, compared with men with normal results, new research from the University of Iowa, Iowa City, shows. 2007-03-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/112007/411602null HTML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Peyronies-Researchers-give-nod-to-autologous-graft/ArticleStandard/Article/detail/408861?contextCategoryId=9398&ref=25 Las Vegas— In their first experiences with xenografts for Peyronie's disease, surgeons at the Mayo Clinic in Jacksonville, FL, decided that Surgisis (Cook Biotech Incorporated, West Lafayette, IN) worked better than Tutoplast (IOP, Inc., Costa Mesa, CA), but the surgeons said they still prefer autologous grafts. 2007-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/102007/408861null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Penile-revascularization-may-benefit-middle-aged-m/ArticleStandard/Article/detail/408859?contextCategoryId=9398&ref=25 Las Vegas—Middle-aged men with erectile dysfunction may benefit from penile microvascular arterial bypass surgery as much as young men do, Boston University researchers reported at the Sexual Medicine Society of North America fall meeting here. 2007-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/102007/408859null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Combination-tretment-may-be-most-effective-in-PE/ArticleStandard/Article/detail/408878?contextCategoryId=9398&ref=25 Las Vegas—The best way to treat premature ejaculation (PE) is through a combination of sex therapy and pharmaceutical management, Michael A. Perelman, PhD, argued at the Sexual Medicine Society of North America fall meeting here. 2007-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/102007/408878null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/Supplement-containing-unlisted-ED-drug-is-recalled/ArticleStandard/Article/detail/407683?contextCategoryId=9398&ref=25 The manufacturer of a sexual performance-enhancing supplement has announced a voluntary recall of the product, known as Liviro3. FDA lab analysis found the product contains the erectile dysfunction drug tadalafil, making Liviro3 an unapproved drug. 2007-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/092007/407683null HTML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Prosthetic-device-for-ED-shows-early-promise/ArticleStandard/Article/detail/408860?contextCategoryId=9398&ref=25 Las Vegas—In a recent trial, men with erectile dysfunction and their partners reported that they were somewhat satisfied with a new wrap-around prosthetic device used to stiffen the men's penises. 2007-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/102007/408860null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/Nearly-one-fifth-of-men-affected-by-ED-data-show/ArticleStandard/Article/detail/407680?contextCategoryId=9398&ref=25 Erectile dysfunction is significantly and independently associated with age, cardiovascular disease, diabetes, and lack of physical activity, suggests a study published in The American Journal of Medicine (2007; 120:151-7). Using data obtained from a computerized self-interview, the authors found that 18.4% of men 20 years of age and older experienced ED, defined as “sometimes able” or “never able” to have and keep an erection. 2007-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/092007/407680null HTML http://www.modernmedicine.com/modernmedicine/Oncology/ED-after-prostate-cancer-treatment-may-be-underrep/ArticleStandard/Article/detail/408876?contextCategoryId=9398&ref=25 Las Vegas—Researchers don't agree on how to measure erectile function and dysfunction, making it difficult to determine the effects of prostate cancer treatment on patients' sex lives, said Johns Hopkins researchers who presented a review of 592 articles at the Sexual Medicine Society of North America fall meeting here. 2007-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/102007/408876null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Agent-shows-promise-for-female-sexual-dysfunction/ArticleStandard/Article/detail/408858?contextCategoryId=9398&ref=25 Las Vegas—An investigational drug that acts on the central nervous system may work as a treatment for female sexual dysfunction (FSD), according to a recent study from New York Presbyterian Hospital/Weill Cornell Medical Center in New York. The drug, bremelanotide, is also being investigated for the treatment of erectile dysfunction in men. 2007-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/102007/408858null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Androgen-deficiency-is-common-in-men-with-ED/ArticleStandard/Article/detail/408857?contextCategoryId=9398&ref=25 Las Vegas—Most men with erectile dysfunction should be tested for androgen deficiency, according to researchers from the University of Minnesota Medical School, Minneapolis. In their study of men with erectile dysfunction, nearly half had testosterone levels less than 400 ng/dL, but they cautioned that the results did not suggest a cause-effect relationship. 2007-03-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/102007/408857null XML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Sexual-enhancement-supplement-recalled-by-manufact/ArticleStandard/Article/detail/401247?contextCategoryId=9398&ref=25 Ebek, Inc., is conducting a voluntary nationwide recall of its supplement product sold under the name Liviro3. Lab analysis of Liviro3 samples conducted by the FDA found the product contains the phosphodiesterase type-5 inhibitor tadalafil, making Liviro3 an unapproved drug. 2007-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/052007/401247null HTML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Male-orgasmic-disorders-What-do-we-know/ArticleStandard/Article/detail/400110?contextCategoryId=9398&ref=25 Orgasm is one of the least understood phases of the sexual response cycle. A physician's understanding of the nature of orgasmic disorders and awareness of available treatment options can have important implications for a patient's and his partner's quality of life. 2007-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/conturo/042007/400110null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Minimally-invasive-surgery-for-GU-cancer-Challengi/ArticleStandard/Article/detail/400354?contextCategoryId=9398&ref=25 There have been major improvements in surgery during the last 150 years in the treatment of genitourinary (GU) oncologic conditions and we're all very aware of its curative nature. Over the past century, great strides have also been made in terms of decreasing mortality rates in patients undergoing surgery, as well as in decreasing morbidity and complications. In the past 15 years, increasing attention has been given to addressing secondary issues such as postoperative pain and the length of hospitalization and recuperation, fostering the development of minimally invasive technologies. 2007-02-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/conturo/042007/400354/MPE_034_thumbnail.jpg http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/conturo/042007/400354null XML http://urologytimes.modernmedicine.com/urologytimes/Sexual+Dysfunction/Gene-transfer-shows-promise-for-erectile-dysfuncti/ArticleStandard/Article/detail/390396?contextCategoryId=9398&ref=25 Early research on the use of gene transfer to treat erectile dysfunction shows promising results and suggests the potential for using the technology to treat overactive bladder and other conditions, according to researchers from North Carolina and New York. 2006-12-07T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/492006/390396null HTML http://urologytimes.modernmedicine.com/urologytimes/Enews/Decline-in-testosterone-levels-seen-among-American/ArticleStandard/Article/detail/390408?contextCategoryId=9398&ref=25 A substantial, yet unrecognized age-dependent population-level decrease in testosterone in American men has been observed, potentially due to birth cohort differences or to health or environmental effects not captured in observed data, suggest researchers from the New England Research Institutes, Watertown, MA. 2006-12-07T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/492006/390408null HTML http://urologytimes.modernmedicine.com/urologytimes/Enews/PDE-5-inhibitor-appears-effective-at-first-dose/ArticleStandard/Article/detail/385987?contextCategoryId=9398&ref=25 Vardenafil (Levitra) appears to be effective at first dose, with continued success in treating erectile dysfunction in men with associated medical conditions, including hypertension, diabetes, and dyslipidemia, the authors of a Canadian study report. 2006-11-16T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/462006/385987null HTML http://urologytimes.modernmedicine.com/urologytimes/Enews/Injectable-enzyme-appears-effective-in-treating-Pe/ArticleStandard/Article/detail/383365?contextCategoryId=9398&ref=25 An investigational injectable enzyme known as AA4500 appears to be effective and generally well tolerated in treating patients with Peyronie's disease, according to data from two phase II open-label trials presented at the recent AUA Western Section annual meeting in Maui, HI. 2006-11-02T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442006/383365null HTML http://urologytimes.modernmedicine.com/urologytimes/Enews/Vacuum-device-label-extended-for-use-during-recove/ArticleStandard/Article/detail/383368?contextCategoryId=9398&ref=25 Timm Medical said the FDA has allowed the company to extend the labeling of its Osbon ErecAid device for use in creating and maintaining erections by providing arterial blood to the penis during recovery from radical prostatectomy. 2006-11-02T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/442006/383368null HTML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Sexual-compulsive-behaviors-ED-drug-misuse-linked/ArticleStandard/Article/detail/384321?contextCategoryId=9398&ref=25 Boston—A study investigating a treatment sample of men diagnosed with sexual compulsivity suggests that prescription and non-prescription use of phosphodiesterase type-5 inhibitors is common in that population. This finding should alert physicians who prescribe medications for erectile dysfunction to maintain an index of patients with a suspected sexual compulsivity problem and to be attentive to clues of potential drug misuse, according to the researchers. 2006-11-01T05:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/452006/384321null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Study-of-PE-drug-shows-efficacy-over-placebo/ArticleStandard/Article/detail/381333?contextCategoryId=9398&ref=25 Minneapolis—For men suffering from the most common sexual dysfunction, premature ejaculation, an investigational drug therapy may offer improved control over ejaculation and sexual satisfaction with a relatively low incidence of side effects. 2006-10-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/432006/381333null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/CAPU-targets-Congress-to-improve-prostheses-fundin/ArticleStandard/Article/detail/377487?contextCategoryId=9398&ref=25 Washington—Members of the Coalition for the Advancement of Prosthetic Urology (CAPU) spent several days during the last week of September pounding the halls on Capitol Hill, lobbying Congress to improve payment for prosthetic urology procedures and seeking comprehensive insurance coverage for prosthetic urologic procedures. Now they wait to see what their efforts may have won. 2006-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/402006/377487null XML http://www.modernmedicine.com/modernmedicine/Inflammation+and+Infection/Data-on-ED-LUTS-offer-unique-opportunity-for-urolo/ArticleStandard/Article/detail/377466?contextCategoryId=9398&ref=25 Several studies presented at the 2006 AUA annual meeting provided evidence of a relationship between erectile dysfunction and lower urinary tract symptoms, with some data showing that treatment of LUTS will improve ED and vice versa. Treating multiple conditions at once means that patients may be able to receive better overall care, but physicians must avoid simply treating symptoms and take a more global approach to patient care, according to Steven A. Kaplan, MD. In this Urology Times interview, Dr. Kaplan, professor of urology and chief of the Institute of Bladder and Prostate Health at Weill Cornell Medical College, Cornell University, New York, discusses current findings on the association between ED and LUTS and their implications for patient management. He was interviewed by UT Editorial Consultant Philip M. Hanno, MD, MPH, professor of urology at the University of Pennsylvania, Philadelphia. 2006-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/402006/377466null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Use-of-PDE-5-inhibitors-declines-with-age-data-sho/ArticleStandard/Article/detail/377486?contextCategoryId=9398&ref=25 Atlanta—Despite media images depicting middle-aged and older men embracing the use of phosphodiesterase type-5 inhibitors to correct erectile dysfunction, actual interest and usage in this population has not been well studied. 2006-10-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/402006/377486null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Shock-waves-may-improve-Peyronies-pain-deviation/ArticleStandard/Article/detail/372167?contextCategoryId=9398&ref=25 Atlanta—Using extracorporeal shockwave therapy (ESWT) to reduce pain and to correct some deviation in Peyronie's disease is a relatively new concept whose application appears to be more extensive in Europe than in the United States. The majority of European studies on this topic involve small cohorts of 30 or fewer patients, and although several have included control groups who did not undergo treatment, none of these trials included sham treatment to define the strength of the placebo effect. 2006-09-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/372006/372167null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Ejaculatory-duct-obstruction-New-approaches-to-dia/ArticleStandard/Article/detail/367656?contextCategoryId=9398&ref=25 Although the presentation of complete and partial EDO can be subtle, refinements in TRUS techniques can help better delineate evidence of obstruction. When properly diagnosed, transurethral treatment is equally effective for both forms of this condition. 2006-09-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/conturo/342006/367656null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/PDE-5-inhibitors-show-efficacy-in-ED-and-LUTS/ArticleStandard/Article/detail/372160?contextCategoryId=9398&ref=25 Atlanta—Sometimes studies are more notable for the questions they raise than for the ones they answer. Kevin T. McVary, MD, professor of urology at Northwestern University Feinberg School of Medicine, Chicago, presented a study at the AUA annual meeting showing that the phosphodiesterase type-5 inhibitor sildenafil citrate (Viagra) improves both erectile function and lower urinary tract symptoms, but has no apparent effect on flow rates. 2006-09-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/372006/372160null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Testosterone-levels-do-not-affect-ED/ArticleStandard/Article/detail/372168?contextCategoryId=9398&ref=25 Atlanta—A cross-sectional analysis of data from the Massachusetts Male Aging Study indicates that there is no relationship between testosterone levels and erectile dysfunction, while elevated levels of luteinizing hormone were associated with a higher prevalence of ED. 2006-09-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/372006/372168null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/ED-stroke-risk-confirmed-ED-NAION-risk-refuted/ArticleStandard/Article/detail/366767?contextCategoryId=9398&ref=25 Urologists attending this year's AUA annual meeting found that erectile dysfunction raises the risk of stroke and heart disease, testosterone is safe in older men, phosphodiesterase type-5 inhibitors do not appear to induce an ocular disorder known as nonarteritic anterior ischemic optic neuropathy (NAION), and aggressive antiseptic washout reduces penile prostheses infections. 2006-08-15T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/342006/366767null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Less-time-trauma-Porcine-graft-benefits-Peyronies/ArticleStandard/Article/detail/364390?contextCategoryId=9398&ref=25 Atlanta—After nearly 30 years of using dermal grafts for reconstruction in Peyronie's disease, Gerald H. Jordan, MD, is switching to porcine small intestinal submucosa (SIS) as the preferred material. It was a studied decision. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/322006/364390null XML http://www.modernmedicine.com/modernmedicine/News/Use-of-androgen-therapy-for-hypogonadism-Safe-or-n/ArticleStandard/Article/detail/362760?contextCategoryId=9398&ref=25 For the two to four million American men who suffer from hypogonadism or "andropause," is treatment with androgen replacement therapy safe, particularly in older men? 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/312006/362760null HTML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Priapism-is-responsive-to-PDE5-inhibitor-therapy/ArticleStandard/Article/detail/364392?contextCategoryId=9398&ref=25 Atlanta—Phosphodiesterase-5 inhibitor therapy, which is commonly used to treat erectile dysfunction, may have a paradoxical benefit as a treatment for priapism in patients with sickle cell anemia, according to research presented at the AUA annual meeting here and at the American Society of Andrology annual meeting in Chicago. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/322006/364392null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Remission-of-ED-appears-more-common-than-believed/ArticleStandard/Article/detail/364388?contextCategoryId=9398&ref=25 Atlanta—Remission of erectile dysfunction may be more common than has been previously believed, according to an analysis of data from the National Institutes of Health-supported Massachusetts Male Aging Study (MMAS). Findings from this analysis were reported at the AUA annual meeting here. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/322006/364388null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/TRT-appears-prostate-safe-in-6-month-trial/ArticleStandard/Article/detail/364386?contextCategoryId=9398&ref=25 Atlanta—Testosterone replacement therapy (TRT) caused no adverse events in the prostate tissue of men with androgen decline of aging male (ADAM) syndrome after 6 months of treatment, according to a study presented at the AUA annual meeting here. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/322006/364386null XML http://www.modernmedicine.com/modernmedicine/Sexual+Dysfunction/Two-Peyronies-procedures-yield-similar-results/ArticleStandard/Article/detail/364391?contextCategoryId=9398&ref=25 Atlanta—Which procedure nets better results for patients with Peyronie's disease—corporeal plication or plaque incision with venous grafting? According to a long-term study from Kaiser Permanente Medical Center in Los Angeles, there is no difference between the two procedures in terms of patient satisfaction. The major difference between the two is time spent in the operating room. 2006-08-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/322006/364391null XML http://www.modernmedicine.com/modernmedicine/BPH/Combo-therapy-packs-double-punch-against-LUTS-ED/ArticleStandard/Article/detail/357762?contextCategoryId=9398&ref=25 Atlanta—Combining an alpha-blocker with a phosphodiesterase-5 (PDE-5) inhibitor appears to produce a greater therapeutic benefit in men with lower urinary tract symptoms than either drug alone, according to a study from Weill Cornell Medical College, New York. 2006-07-01T04:00:00Z http://urologytimes.modernmedicine.com/urologytimes/data/articlestandard/urologytimes/282006/357762null XML